SM
Sabby Management Portfolio holdings
AUM
$13M
This Quarter Return
+3.7%
1 Year Return
-26.95%
3 Year Return
-56.43%
5 Year Return
-61.92%
10 Year Return
-71.17%
AUM
$77M
AUM Growth
+$77M
(+167%)
Cap. Flow
+$44.1M
Cap. Flow
% of AUM
57.26%
Top 10 Holdings %
Top 10 Hldgs %
76.76%
Holding
105
New
31
Increased
5
Reduced
14
Closed
38
Top Buys
| 1 |
Biogen
BIIB
|
$27.8M |
| 2 |
Health Care Select Sector SPDR Fund
XLV
|
$7.09M |
| 3 |
Moderna
MRNA
|
$4.62M |
| 4 |
Xeris Biopharma Holdings
XERS
|
$2.89M |
| 5 |
PLLL
Piedmont Lithium Limited American Depositary Receipts
PLLL
|
$2.88M |
Top Sells
| 1 |
SPDR Gold Trust
GLD
|
$2.66M |
| 2 |
Enlivex Therapeutics
ENLV
|
$2.18M |
| 3 |
NOVN
Novan, Inc. Common Stock
NOVN
|
$2.11M |
| 4 |
Outlook Therapeutics
OTLK
|
$1.94M |
| 5 |
Pluri
PLUR
|
$1.44M |
Sector Composition
| 1 | Healthcare | 73.93% |
| 2 | Industrials | 1.66% |
| 3 | Consumer Discretionary | 0.57% |
| 4 | Financials | 0.41% |
| 5 | Consumer Staples | 0.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Biogen
BIIB
$19.4B
| $27.8M | 5.58% | +103,902 | New | +$27.8M |
|
|
2
Health Care Select Sector SPDR Fund
XLV
$33.9B
| $10.5M | 2.11% | 105,280 +70,870 | +206% | +$7.09M |
|
|
3
Moderna
MRNA
$9.37B
| $4.62M | 0.93% | +71,893 | New | +$4.62M |
|
|
4
Xeris Biopharma Holdings
XERS
$1.26B
| $2.89M | 0.58% | +1,086,031 | New | +$2.89M |
|
|
PLLL
5
DELISTED
Piedmont Lithium Limited American Depositary Receipts
PLLL
| $2.88M | 0.58% | +498,259 | New | +$2.88M |
|
6
Curis
CRIS
$20.9M
| $2.74M | 0.55% | +2,267,068 | New | +$2.74M |
|
|
ALNA
7
DELISTED
Allena Pharmaceuticals, Inc. Common Stock
ALNA
| $2.42M | 0.49% | +1,531,446 | New | +$2.42M |
|
|
MTVA
8
MetaVia Inc. Common Stock
MTVA
$15.3M
| $1.87M | 0.38% | +232,547 | New | +$1.87M |
|
|
ODT
9
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
| $1.72M | 0.34% | 40,500 -8,488 | -17% | -$359K |
|
10
AstraZeneca
AZN
$248B
| $1.66M | 0.33% | +31,320 | New | +$1.66M |
|
11
FibroGen
FGEN
$47.8M
| $1.36M | 0.27% | +33,560 | New | +$1.36M |
|
12
CEL-SCI Corp
CVM
$71.8M
| $1.32M | 0.26% | 88,417 +33,382 | +61% | +$498K |
|
13
Globus Maritime Ltd
GLBS
$21.4M
| $1.28M | 0.26% | +4,776,735 | New | +$1.28M |
|
14
iShares Biotechnology ETF
IBB
$5.6B
| $1.25M | 0.25% | +9,130 | New | +$1.25M |
|
|
NKLAW
15
DELISTED
Nikola Corporation Warrant expiring 6/3/2025
NKLAW
| $1.15M | 0.23% | +34,500 | New | +$1.15M |
|
16
Celldex Therapeutics
CLDX
$1.47B
| $950K | 0.19% | +73,094 | New | +$950K |
|
17
scPharmaceuticals
SCPH
$295M
| $926K | 0.19% | +125,752 | New | +$926K |
|
|
PAVMZ
18
DELISTED
PAVmed Inc. Series Z Warrant
PAVMZ
| $867K | 0.17% | 842,210 -193,186 | -19% | -$199K |
|
|
SOLY
19
DELISTED
Soliton, Inc.
SOLY
| $800K | 0.16% | +102,891 | New | +$800K |
|
|
NVCN
20
DELISTED
Neovasc Inc.
NVCN
| $776K | 0.16% | +326,023 | New | +$776K |
|
21
Mustang Bio
MBIO
$10.9M
| $747K | 0.15% | +234,778 | New | +$747K |
|
|
AVGR
22
DELISTED
Avinger, Inc. Common Stock
AVGR
| $676K | 0.14% | 2,183,464 +1,615,064 | +284% | +$500K |
|
23
Immunic
IMUX
$80.9M
| $642K | 0.13% | +53,009 | New | +$642K |
|
|
AVEO
24
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
| $450K | 0.09% | 87,319 -24,836 | -22% | -$128K |
|
25
Yatra Online
YTRA
$86.3M
| $441K | 0.09% | +650,000 | New | +$441K |
|